Search filters
Filters
Clear AllPhase
-
183
-
156
-
2
-
194
-
1
-
152
-
17
-
402
Age
-
1246
-
593
Gender
-
29
-
49
-
3
-
1172
Virtual Trials
-
1247
-
6
New Trials
-
4
-
1249
Loading...
Found 1253 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
ABC008-IBM-201: A Phase II/III Randomized Double-blind Placebo-controlled Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis
dosing of ABC008 in subjects with inclusion body myositis (IBM).
Multi-center parallel-group randomized controlled trial of modified natural versus programmed cycles for frozen embryo transfers and their association with preeclampsia and live births (NatPro)
The primary objective is to determine the proportion of preeclampsia in pregnant women assigned to a modified natural cycle FET (corpus luteum present) protocol compared to a programmed FET (corpus luteum absent) protocol.
Hyperpolarized xenon functional lung imaging in COPD patients undergoing targeted lung denervation
For information regarding study objectives, please see section 8 of the attached protocol. In the context of targeted lung denervation (TLD), we expect the most informative aspect of altered lung function to be related to regional ventilation, as well as possibly the timing of regional inhaled/exhaled gas flow with respect …
Verification of Risk Assignment for Whole Chromosome Aneuploidy using SNP-based NIPT in VaniSHing Twin Pregnancies
The main objective of this study is to collect clinical data and blood samples from women with either ultrasound-documented vanishing twin pregnancy or whose Panorama test results suggest increased risk for vanishing twin, and cheek swab samples on their newborn baby to improve the ability of Nateras Panorama (cell free …
A5394: Safety Tolerability and Impact of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants with Both Chronic Hepatitis B and HIV
A5394 is a phase II, randomized, double-blind, placebo-controlled clinical trial to assess the safety, tolerability, and efficacy of 24 weeks of treatment with Selgantolimod (SLGN). Intensive PK sampling will be conducted in the first 12 participants who enroll into the study.
Study Evaluating Maternal and FetaL Outcomes in the ERA of ModulatorS (MAYFLOWERS)
The purpose of any research study is to answer questions. The MAYFLOWERS study is being done to look at how pregnancy affects the health of women with cystic fibrosis (CF) and to look at the health of babies born to women with CF. It is expected that most but not …
Predicting Epilepsy Surgery Outcomes Using Neural Network Architecture
The purpose of this study is to test, in surgery patients and controls aged 18 to 65, whether measurable abnormalities found in pre-surgical MRI can predict surgical outcomes in epilepsy, to improve the understanding for the causes of surgical failure, and to pave the way for future use of neuroimaging …
Improving Sleep in the Neurology In-Patient Population
The research is being conducted to improve sleep in the inpatient neurology population by decreasing overnight interruptions and addressing environmental barriers to sleep in the hospital. If you agree to join this study, you will be asked to complete the following research procedures: wear an activity and sleep monitor (FitBit), …
Remote Blood Biomarker Monitoring in Frontotemporal Lobar Degeneration: Neurofilament Survillance Project (NSP)
This is a biomarker study designed to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) mutations compared to a control group of individuals without known f-FTLD mutations.
Study to establish the safety of reducing radiation dose in selected p16+ OPSCC patients receiving adjuvant radiation after Transoral Robotic Surgery (TORS) and neck dissection
The main purpose of this research study is to determine the likelihood of cancer growing back in the throat or in the neck, 2 years after completion of radiation, if lower doses of radiation are used to a smaller area of the head and neck region, than is currently the …
Please choose between Voice or SMS based delivery of verification code
or